Gastrointestinal Neoplasia, An Issue of Gastroenterology Clinics of North America, 1st Edition
Author :
By Paul J. Limburg, MD and Dan A. Dixon, PhD
Gastrointestinal (GI) cancers account for nearly 150,000 deaths each year, in the United States alone. Encouragingly, environmental risk factors, premalignant conditions, and high-risk familial kindreds are well described for many GI cancers. In th
...view more
Gastrointestinal (GI) cancers account for nearly 150,000 deaths each year, in the United States alone. Encouragingly, environmental risk factors, premalignant conditions, and high-risk familial kindreds are well described for many GI cancers. In this comprehensive volume on GI Neoplasia, all luminal cancers will be discussed, along with pancreas cancer, gastrointestinal stromal tumors (GISTs), carcinoid tumors, and neuroendocrine tumors. Hepatobiliary cancers are not addressed, as these tumors could form the basis of a separate volume. Articles are organized to address several key topics for each cancer type, such as: public health burden, molecular pathways, risk and protective factors, early detection, clinical evaluation, management, and survivorship.
Gastrointestinal (GI) cancers account for nearly 150,000 deaths each year, in the United States alone. Encouragingly, environmental risk factors, premalignant conditions, and high-risk familial kindreds are well described for many GI cancers. In this comprehensive volume on GI Neoplasia, all luminal cancers will be discussed, along with pancreas cancer, gastrointestinal stromal tumors (GISTs), carcinoid tumors, and neuroendocrine tumors. Hepatobiliary cancers are not addressed, as these tumors could form the basis of a separate volume. Articles are organized to address several key topics for each cancer type, such as: public health burden, molecular pathways, risk and protective factors, early detection, clinical evaluation, management, and survivorship.
Author Information
By Paul J. Limburg, MD, Mayo Clinic Rochester, Rochester, MN and Dan A. Dixon, PhD, Kansas University Medical Center, Kansas City, Kansas
https://www.asia.elsevierhealth.com/gastrointestinal-neoplasia-an-issue-of-gastroenterology-clinics-of-north-america-9780323462570.html294907Gastrointestinal Neoplasia, An Issue of Gastroenterology Clinics of North Americahttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9780323462570_8.jpg89.0998.99USDInStock/Medicine & Surgery/Gastroenterology & Hepatology/Clinics/Medicine/Gastroenterology & Hepatology/Clinics/Clinics/Medicine/Gastroenterology & Hepatology/Japan Titles43351394388725505460750546665255041525989452631601418269243350884886536505455351451205259833Gastrointestinal (GI) cancers account for nearly 150,000 deaths each year, in the United States alone. Encouragingly, environmental risk factors, premalignant conditions, and high-risk familial kindreds are well described for many GI cancers. In this comprehensive volume on GI Neoplasia, all luminal cancers will be discussed, along with pancreas cancer, gastrointestinal stromal tumors (GISTs), carcinoid tumors, and neuroendocrine tumors. Hepatobiliary cancers are not addressed, as these tumors could form the basis of a separate volume. Articles are organized to address several key topics for each cancer type, such as: public health burden, molecular pathways, risk and protective factors, early detection, clinical evaluation, management, and survivorship. Gastrointestinal (GI) cancers account for nearly 150,000 deaths each year, in the United States alone. Encouragingly, environmental risk factors, premalignant conditions, and high-risk familial kindreds are well described for many GI cancers. In this comprehensive volume on GI Neoplasia, all luminal cancers will be discussed, along with pancreas cancer, gastrointestinal stromal tumors (GISTs), carcinoid tumors, and neuroendocrine tumors. Hepatobiliary cancers are not addressed, as these tumors could form the basis of a separate volume. Articles are organized to address several key topics for each cancer type, such as: public health burden, molecular pathways, risk and protective factors, early detection, clinical evaluation, management, and survivorship.00add-to-cart97803234625702016ProfessionalBy Paul J. Limburg, MD and Dan A. Dixon, PhD20161Book152w x 229h (6.00" x 9.00")Elsevier0Aug 29, 2016IN STOCKBy <STRONG>Paul J. Limburg</STRONG>, MD, Mayo Clinic Rochester, Rochester, MN and <STRONG>Dan A. Dixon</STRONG>, PhD, Kansas University Medical Center, Kansas City, KansasClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select